Treatment of refractory whipple disease with interferon-γ

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 875-877

  Schneider, Thomas ^a   Stallmach, Andreas ^a   Von Herbay, Axel ^b   Marth, Thomas ^a   Strober, Warren ^c   Zeitz, Martin ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; RECOMBINANT GAMMA INTERFERON; RIFAMPICIN; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; INTESTINE LIPODYSTROPHY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032401736     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_1-199812010-00006     Document Type: Article

References (17)

1. Fleming JL, Wiesner RH, Shorter RG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539-51.
2. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med. 1992;327:293-301.
3. Schoedon G, Goldenberger D, Forrer R, Gunz A, Dutly F, Höchli M, et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J Infect Dis. 1997;176:672-7.
4. Paulley JW. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology. 1952; 22:128-33.
5. Feurle GE, Volk B, Waldherr R. Cerebral Whipple's disease with negative jejunal histology. N Engl J Med. 1979;300:907-8.
6. Feldman M, Hendler RS, Morrison EB. Acute meningoencephalitis after withdrawal of antibiotics in Whipple's disease. Ann Intern Med. 1980;93:709-11.
7. Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3d. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology. 1985;88:1867-73.
8. Maizel H, Ruffin JM, Dobbins WO 3d. Whipple's disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine (Baltimore). 1970;49:175-205.
9. Martin FF, Vilseck J, Dobbins WO 3d, Buckley CE 3d, Tyor MP. Immunological alterations in patients with treated Whipple's disease. Gastroenterology. 1972;63:6-18.
10. Bjerknes R, Odegaard S, Bjerkvig R, Borkje B, Laerum OD. Whipple's disease. Demonstration of a persisting monocyte and macrophage dysfunction. Scand J Gastroenterol. 1988;23:611-9.
11. Ectoers N, Geboes K, Rutgeerts P, Delabie J, Desmet V, Janssens J. RFD7-RFD9 coexpression by macrophages points to T cell macrophage interaction deficiency in Whipple's disease [Abstract]. Gastroenterology. 1992; 106:A676.
12. Marth T, Roux M, von Herbay A, Meuer SC, Feurle GE. Persistent reduction of complement receptor 3 α-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease. Clin Immunol Immunopathol. 1994;72:217-26.
13. Marth T, Neurath M, Cuccherini BA, Strober W. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology. 1997;113:442-8.
14. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med. 1994; 330:1348-55.
15. Gallin JI, Farber JM, Holland SM, Nutman TB. Interferon-γ in the management of infectious diseases. Ann Intern Med. 1995;123:216-24.
16. von Herbay A, Ditton HJ, Maiwald M. Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsies. Gastroenterology. 1996; 110:1735-43.
17. von Herbay A, Ditton HJ, Schuhmacher F, Maiwald M. Whipple's disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology. 1997;113:434-41.